This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
HIV Vaccines: Current Challenges and Future Prospects
joint with HIV Pathogenesis
Organizer(s): David C. Montefiori, Kent J. Weinhold and Carolyn Williamson
Date: April 09 - 15, 2005
Location: Fairmont Banff Springs, Banff, AB, Canada
Part of the Global Health Series, Supported by the Bill & Melinda Gates Foundation, and Sponsored by Wyeth Vaccines Research
Summary of Meeting:
The need to develop a vaccine for AIDS has never been so urgent. The number of people infected with HIV has grown to over 40 million and continues to increase at an alarming rate in many developing countries. The disappointing results of AIDSVAX, the first candidate HIV vaccine to be tested in phase III efficacy trials, underscore the need for heightened efforts. A variety of candidate HIV vaccines are tested in animal models and phase I/II clinical trials every year, yielding new information on safety, immunogenicity and potential efficacy. Moreover, considerable efforts are underway to gain a better understanding of the genetic diversity and antigenic structure of the virus, the immune responses that contain HIV infection, and the complex mechanisms used by the virus to evade those immune responses. Investigators hope to use this collective information to engineer improved immunogens. This Keystone Symposium aims to address the scientific obstacles to vaccine development, to identify promising leads that may help overcome those obstacles, to foster open scientific discussions of the most recent unpublished results from pre-clinical and clinical trials and to forge new collaborations that will accelerate the development of a safe and effective HIV vaccine.
Discounted Abstract Deadline: December 9 2004
Discounted Registration Deadline: February 10 2005
We gratefully acknowledge additional support for this conference from:
Bill & Melinda Gates FoundationOffice of AIDS Research, NIHWyeth Vaccines Research
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck Research Laboratories

Wyeth Research Labs
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13-AI063798-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found